Houston Chronicle

Early screening, a critical tool in fight against lung cancer

-

Dr. Philip Rascoe is an associate professor in the Department of Cardiothor­acic and Vascular Surgery at McGovern Medical School at UTHealth Houston and a cardiothor­acic surgeon affiliated with Memorial Hermann.

Dr. Kiran Nair is a pulmonolog­ist affiliated with Memorial Hermann.

Each year in the United States, approximat­ely 218,500 people are diagnosed with lung cancer, and about 142,000 people die from the disease, according to the Centers for

Disease Control and Prevention (CDC). November is Lung Cancer Awareness Month, an opportunit­y for physicians and specialist­s to share important informatio­n related to this disease, which is the leading cause of cancer death in both men and women in the U.S. Below, cardiothor­acic surgeon Dr. Philip Rascoe and pulmonary specialist Dr. Kiran Nair discuss risk factors related to lung cancer, the importance of regular screening and early detection, as well as the latest treatment options available.

Q: What are the signs and symptoms of lung cancer? Dr. Nair:

There are no specific signs or symptoms of lung cancer, which is why screening asymptomat­ic high-risk patients is so important. By the time someone usually has any symptoms, it typically means that you have advanced disease. With that said, symptoms can include persistent cough or shortness of breath, coughing up blood and localized pain in your chest.

Q: What are some of the risk factors for lung cancer? Dr. Nair:

Significan­t smoking history is the No. 1 risk factor for lung cancer, with smokers making up 90 percent of lung cancer cases. You should also stay away from secondhand smoke, since nonsmokers who are exposed to secondhand smoke increase their risk of getting lung cancer by 20 percent to 30 percent. Other risk factors include genetic or familial history as well as exposure to certain radiation or chemicals, but those cases are less common.

As doctors who treat lung cancer patients, we cannot stress enough the importance of quitting smoking, and Memorial Hermann offers programs to help anyone who is looking to do so.

There are many methods available and we can help you find what will work best for you, including medication­s or pharmacolo­gic agents, nicotine replacemen­t therapies, counseling, support groups and more.

Q: What type of lung cancer screening options are available for high-risk patients?

Dr. Rascoe:

Historical­ly, a standard chest X-ray has not proven to be beneficial for screening smokers for potential lung cancers, but in the past decade, Low-Dose Computed

Tomography (LDCT) scans have been shown to be a very good screening tool for patients who are at high risk for lung cancer. These guidelines have recently been revised to include patients who are 50 to 80 years of age with a smoking history that equates to roughly a pack a day for 20 years. Anyone who fits the criteria is eligible for this annual LDCT screening, and we highly recommend it. Importantl­y, right now only a very low percentage of the population eligible for this screening is accessing it, so we want to get the word out and recommend this to anyone who might qualify, as it can catch lung cancer early, which means better treatment and survival rates.

Q: What type of lung cancer screening options are available for high-risk patients?

Dr. Nair:

The Lung Cancer Multidisci­plinary Program is a team-based approach where we have specialist­s from all of our lung cancer management teams collaborat­ing on cases. This involves the pulmonolog­ist, the surgeon, the radiologis­t, pathologis­t and oncologist putting all of our expertise together to provide a more comprehens­ive approach to the management of each patient’s cancer.

Dr. Rascoe: A great example of this is in a tumor board setting where there is expertise offered from each of those specialtie­s. Even more, we work together with Oncology Nurse Navigators to coordinate appointmen­ts for patients, so they can see every specialist they need to see on the same day, rather than coming back for a separate appointmen­t with the medical oncologist or the surgeon, for example. It truly is a multidisci­plinary effort that focuses on collaborat­ion for the benefit of the patient and allows us to provide high-quality, exemplary care.

Do you fall into a high-risk category for lung cancer? Are you concerned about possible symptoms?

Learn more about Memorial Hermann’s comprehens­ive services at memorialhe­rmann. org/lungcancer

 ?? ??
 ?? ?? Dr. Philip Rascoe, MD
Dr. Philip Rascoe, MD
 ?? ?? Dr. Kiran Nair, DO
Dr. Kiran Nair, DO
 ?? Photo courtesy of Memorial Hermann ??
Photo courtesy of Memorial Hermann

Newspapers in English

Newspapers from United States